Академический Документы
Профессиональный Документы
Культура Документы
M.L. is a 50-year-old white female who has been working in the front office of a medical clinic for the
past five years. She has made an appointment to see her primary care provider because she has been
feeling very tired for the past month and has also been suffering from stiffness, pain, and swelling in
multiple joints. “I ache all over,” she told her PCP, “and I have pain in different places all the time. One
day it is in my right shoulder, the next day in my right wrist, and the following day in my left wrist. I’m
stiff everywhere when I get up in the morning or if I sit for any length of time. And I feel so tired, like I
have a case of the flu that won’t go away.” The patient is allergic to IV iron dextran from which she has
developed shortness of breath. She rarely uses alcohol and does not smoke. She is taking an over-the-
counter calcium supplement, levothyroxine sodium, and venlafaxine. There is no family history of
rheumatoid arthritis.
References:
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2016). Fever and the thermal regulation of immunity:
The immune system feels the heat. Nature Reviews Immunology.
Heidari, B. (2011). Caspian Journal of Internal Medicine. Rheumatoid Arthritis: Early diagnosis
and treatment outcomes.
Rheumatoid Arthritis. Retrieved April 26, 2020 from https://www.mayoclinic.org/diseases-
conditions/rheumatoid-arthritis/symptoms-causes/syc-20353648
Wolff, D. (2008). XPharm: The Comprehensive Pharmacology Reference. Rheumatoid Arthritis.
References:
Chew et al. (2017). What Your Patients Need to Know About Psychiatric Medications (3 rd Ed).
Venlafaxine, pp 152. American Psychiatric Association Publishing.
Schatzberg, A.F., & Nemeroff, C.B. (2009). The American Psychiatric Publishing Textbook of
Psychopharmacology (4th Ed). Chapter 22 Venlafaxine and Desvenlafaxine, pp 441. American
Psychiatric Publishing Inc.
Venlafaxine. Retrieved April 26, 2020 from https://pubchem.ncbi.nlm.nih.gov/compound/
Patient Case Question 3
Identify two abnormal findings from the physical exam above that are consistent with rheumatoid
arthritis.
Patient M.L. “appears very tired”. Fatigue and malaise are common symptoms of RA. Studies
show that up to 80% of people with RA have at least some sense of feeling run down, and more
than 50% have high levels of fatigue.
Mild lymphadenopathy. More than 50% of patients with rheumatoid arthritis (RA) exhibit
lymphadenopathy and reactive follicular hyperplasia. Lymphadenopathy can occur in the nodes
near the affected joints.
References:
Hsi, E.D. (2012). Hematopathology. Reactive lymph nodes chapter 4, pp 136. Elsevier Inc.
RA and Fatigue. Retrieved April 26, 2020 from https://www.webmd.com/rheumatoid-
arthritis/ra-fight-fatigue#1
Saito et al. (2014). Hindawi Journals. A Case of Rheumatoid Arthritis.
Are rheumatoid nodules, lesions containing lymphocytes and dead cell debris that are
characteristic of rheumatoid arthritis. Rheumatoid nodules are firm, noticeable lumps that form
underneath the skin of some rheumatoid arthritis patients. They generally form on or near the
base of the arthritic joints. They are a symptom that is unique to rheumatoid arthritis.
The nodules can be present in the acute and chronic stages of the disease. Most commonly,
rheumatoid nodules develop in patients already living with rheumatoid arthritis for some time.
References:
Ezerioha, M. (2018). Rheumatoid Nodules: Are Rheumatoid Nodules Dangerous. Retrieved from
https://www.rheumatoidarthritis.org/ra/symptoms/rheumatoid-nodules/
Villines, Z. (2017). What are rheumatoid nodules? Retrieved April 27, 2020 from
https://www.medicalnewstoday.com/articles/319839
The distal interphalangeal (DIP) joints are generally spared in Rheumatoid arthritis, this is a
distinguishing characteristic that helps to differentiate RA from osteoarthritis. It is more
common for DIP joints to be affected by osteoarthritis than by RA.
The joints involved most frequently are the proximal interphalangeal (PIP) and
metacarpophalangeal (MCP) joints of the hands, the wrists, and small joints of the feet including
the metatarsophalangeal (MTP) joints. The shoulders, elbows, knees, and ankles are also
affected in many patients.
References:
References:
Patient M.L. is taking levothyroxine. Levothyroxine used to treat thyroid hormone deficiency.
Because the patient has symptoms of fatigue and malaise, it is appropriate to determine her
serum TSH in order to attribute these symptoms to thyroid dysfunction or possibly another
condition, such as RA.
TSH concentration aids in differentiating hypothyroidism. A TSH test is also used to find out how
well the thyroid is working. This test would be considered appropriate given the symptoms.
References:
The reason for the testing of the uric acid is to rule out other conditions which present with
similar clinical manifestations as RA, like gouty arthritis. Elevated serum levels of uric acid are
consistent with a diagnosis of gouty arthritis. Patient M.L. has 2.9 mg/dL of uric acid level and
it’s within the normal limits of 2.5 to 7.5 mg/dL for females.
References:
American college of physicians. (2008). MKSAP for Students 4: Medical Knowledge Self-
assessment Program.
Brown, J. (2018). Gout vs. Rheumatoid Arthritis. Retrieved from
https://creakyjoints.org/symptoms/gout-vs-rheumatoid-arthritis/
Gabbey, A.E., & Nall, R. (2017). Uric Acid Test (Blood Analysis). Retrieved from
https://www.healthline.com/health/uric-acid-blood
With the main goal to reduce the inflammation and pain while preserving joint function and
preventing deformities, the first class of drugs for RA is NSAID. NSAIDs work to reduce the levels
of inflammation in the joints, thus relieving pain and restoring mobility. Examples of NSAIDs
commonly used are ibuprofen and naproxen, prescription NSAIDs like celecoxib may also be
prescribed as they offer a higher dose with longer-lasting results and require fewer doses
throughout the day.
For severe joint damage, disease-modifying antirheumatic drugs (DMARDs) like methotrexate
are used. DMARDs interfere with the autoimmune attacks occurring in rheumatoid arthritis
patients, these medications also aim to preserve the joint structure and reduce the progression
of early rheumatoid arthritis.
References:
Duckworth, H. (2018). RA Medications: Are NSAIDs or DMARDs Better for Pain? Retrieved from
https://www.rheumatoidarthritis.org/treatment/medications/nsaids-vs-dmards/
Lemke, T.L., & Williams, D.A. (2008). Foye's Principles of Medicinal Chemistry. Chapter 36:
Nonsteroidal Anti-inflammatory Drugs pp 989. Lippincott Williams & Wilkins.
Rheumatoid Arthritis Drug Guide. Retrieved April 27, 2020 from
https://www.webmd.com/rheumatoid-arthritis/rheumatoid-arthritis-medications#1
Understanding Rheumatoid Arthritis – Treatment. Retrieved April 27, 2020 from
https://www.webmd.com/rheumatoid-arthritis/understanding-rheumatoid-arthritis-
treatment#1
Patient Case Question 10
In terms of the progression of the disease, what do the results of the hand x-ray suggest?
The earliest sign of RA is a periarticular soft-tissue swelling. As seen in the hand x-ray of the
patient, soft tissue swelling and bone demineralization are present. This suggests that the
patient has had RA for more than 6 months’ time but has not had the condition long enough to
cause significant radiographic changes associated with RA along with the evidence that there’s
still no erosion in the bones.
Bone erosion happens in stage 3 of rheumatoid arthritis.
References:
Freeman, J. (2018). RA Progression: What are the Signs of Rheumatoid Arthritis Progression?
Retrieved April 27, 2020 from https://www.rheumatoidarthritis.org/ra/symptoms/progression/
Lovering, C. (2019). Four Stages and Progression of Rheumatoid Arthritis. Retrieved April 27,
2020 from https://www.healthline.com/health/rheumatoid-arthritis/stages-and-progression.
Newman, E.D., & Matzko, C. (2008). Rheumatoid Arthritis FAQs. Geisinger Clinic and Decker Inc.
Tsou, I.Y. (2019). Rheumatoid Arthritis Hand Imaging. Medscape Articles.
References:
Cole, J.D. (2014). Diagnosis through Synovial Fluid Analysis. Retrieved April 27, 2020 from
https://www.arthritis-health.com/treatment/joint-aspiration/diagnosis-through-synovial-fluid-
analysis
Faryna, A., & Goldenberg, K. (1990). Clinical Methods: The History, Physical, and Laboratory
Examinations. (3rd Ed.). Chapter 166 Joint Fluid. Boston.
Smith, H.R. (2020). Rheumatoid Arthritis (RA) Workup. Retrieved April 27, 2020 from
https://emedicine.medscape.com/article/331715-workup#c11
In the early course of RA, joint mobility is reduced due to the initial inflammatory response. The
inflammatory response includes vasodilation in the tissues of the affected joint in response to
the production of histamine, prostaglandins and other cytokines. Vasodilation increases blood
flow, causes the symptoms of warmth and redness while swelling is caused by increased
capillary permeability that accompanies inflammation and vasodilation. The swelling of the joint
is the initial cause of loss of joint mobility. The inflammatory response eventually goes on to
erode bone and cartilage and destroy the joint.
References:
Heidari, B. (2011). Caspian Journal of Internal Medicine. Rheumatoid Arthritis: Early diagnosis
and treatment outcomes.
Kandola, A. (2018). Rheumatoid arthritis (RA): Prognosis. Retrieved from
https://www.medicalnewstoday.com/articles/323631
Limitation of motion occurs as a result of articular surface damage, joint and tendon sheath
swelling, or alteration of joint supporting structures. Effusion may limit joint motion through
pain or by causing sufficient tightness of the joint capsule to impede joint mobility. Fibrosis
involving tendons and muscles may limit normal joint motion and result in flexion contractures.
In the later course of RA, significant inflammation causes small blood vessels to become
obstructed with microthrombi composed of fibrin and platelets. The body tries to compensate
for the compromised blood flow by creating a new network of blood vessels in the synovial
membranes. This tissue is known as pannus, the formation of pannus is a characteristic feature
of RA that distinguishes it from other forms of arthritis. The pannus extends from the synovium
to the unprotected bone and leads to the formation of scar tissue within the joint space. Scar
tissue ultimately reduces joint motion and leads to joint immobilization.
References:
Reynolds, W.E. (1995). Medical Clinics of North America. The Clinical Manifestations of
Rheumatoid Arthritis, Volume 39, Issue 2, March 1955, Pages 365-377.
https://doi.org/10.1016/S0025-7125(16)34694-6
Smith, H.R. (2020). Rheumatoid Arthritis (RA) Clinical Presentation. Retrieved from
https://emedicine.medscape.com/article/331715-clinical#b4
Xiu, P. (2012). Crash Course Pathology (4th Ed). Elsevier Inc.